Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 222,476 | 180,971 | 216,655 | 248,107 | 262,612 |
| Receivables | 2,029 | 1,849 | 1,275 | 3,272 | 1,307 |
| Inventories | 3,149 | 2,096 | 1,821 | 194 | 196 |
| Other current assets | 2,666 | 2,666 | 2,490 | 12,096 | 0 |
| TOTAL | $238,836 | $195,752 | $228,727 | $268,930 | $271,894 |
| Non-Current Assets | |||||
| PPE Net | 1,303 | 1,388 | 837 | 668 | 775 |
| Intangibles | 17,260 | 17,260 | 17,260 | 17,260 | 17,260 |
| Other Non-Current Assets | 63,823 | 14,614 | 14,437 | 15,193 | 6,516 |
| TOTAL | $82,386 | $33,262 | $32,534 | $33,121 | $24,551 |
| Total Assets | $321,222 | $229,014 | $261,261 | $302,051 | $296,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,950 | 5,394 | 6,369 | 6,516 | 7,222 |
| Accrued Expenses | 25,365 | 23,034 | 21,103 | 35,951 | 20,884 |
| Other current liabilities | 5,504 | 5,005 | 4,035 | 2,880 | 5,043 |
| TOTAL | $37,819 | $43,591 | $31,507 | $45,347 | $33,149 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 10,080 | 10,004 | 9,929 |
| Other Non-Current Liabilities | 183,332 | 71,746 | 71,488 | 71,092 | 71,651 |
| TOTAL | $183,332 | $71,746 | $81,568 | $81,096 | $81,580 |
| Total Liabilities | $221,151 | $115,337 | $113,075 | $126,443 | $114,729 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,701 | 19,613 | 19,576 | 19,362 | 19,279 |
| Common Shares | 207 | 196 | 195 | 193 | 193 |
| Retained earnings | -421,033 | -383,233 | -343,284 | -300,850 | -289,888 |
| Other shareholders' equity | 7,982 | 8,022 | 7,999 | 875 | -952 |
| TOTAL | $100,071 | $113,677 | $148,186 | $175,608 | $181,716 |
| Total Liabilities And Equity | $321,222 | $229,014 | $261,261 | $302,051 | $296,445 |